Cross-Strait Taiwan Tensions, COVID, And Clinical Trials: An Interview With TLC President Yeh

 
• By Brian Yang

A recent survey showed healthcare as among the sectors US companies were most concerned about amid the ongoing China-US tensions over Taiwan. But how do biotech firms on the island itself view the current situation? We spoke to the president of one amid Taiwan’s imminent reopening.

China and US standoff over Taiwan raises risks for health players
RISING TENSIONS OVER TAIWAN HEIGHTEN HEALTH SECTOR RISKS, RECENT SURVEY SHOWS • Source: Shutterstock

More from Drug Safety

More from Pink Sheet